Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 10, 2010, Pages 1107-1114

  Balvers, Michiel G J ^a,b,c   Verhoeckx, Kitty C M ^a   Plastina, Pierluigi ^c   Wortelboer, Heleen M ^a   Meijerink, Jocelijn ^b   Witkamp, Renger F ^a,b  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Adipocytes; DHA; EPA; Inflammation; N acyl ethanolamines

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOYL ETHANOLAMINE; EICOSAPENTANAENOYL ETHANOLAMINE; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACYL ETHANOLAMINE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN 3T3; ENZYME STRUCTURE; ENZYME SYNTHESIS; NONHUMAN; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL2; CULTURE MEDIA; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ETHANOLAMINES; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MASS SPECTROMETRY; MICE;

EID: 77955508948     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.06.006     Document Type: Article

References (33)

1. Riediger N.D., Othman R.A., Suh M., Moghadasian M.H. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Diet. Assoc. 2009, 109:668-679.
2. Carpentier Y.A., Portois L., Malaisse W.J. n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 2006, 83:S1499-S1504.
3. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 2008, 47:147-155.
4. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
5. Hoareau L., Buyse M., Festy F., Ravanan P., Gonthier M.P., Matias I., Petrosino S., Tallet F., d'Hellencourt C.L., Cesari M., Di Marzo V., Roche R. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity 2009, 17:431-438.
6. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., Friedman H. The cannabinoid system and immune modulation. J. Leukoc. Biol. 2003, 74:486-496.
7. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 2005, 5:400-411.
8. O'Sullivan S.E. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 2007, 152:576-582.
9. Bisogno T., Ligresti A., Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 2005, 81:224-238.
10. Bisogno T. Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol 2008.
11. Di Marzo V., Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 2007, 18:129-140.
12. Artmann A., Petersen G., Hellgren L.I., Boberg J., Skonberg C., Nellemann C., Hansen S.H., Hansen H.S. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 2008, 1781:200-212.
13. Batetta B., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., Giordano E., Sanna F., Bisogno T., Uda S., Collu M., Bruheim I., Di Marzo V., Banni S. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J. Nutr. 2009, 139:1495-1501.
14. Matias I., Carta G., Murru E., Petrosino S., Banni S., Di Marzo V. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim. Biophys. Acta 2008, 1781:52-60.
15. Weisberg S.P., McCan S., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 15.
16. Naugler W.E., Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 2008, 14:109-119.
17. Sell H., Dietze-Schroeder D., Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol. Metab. 2006, 17:416-422.
18. Sell H., Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr. Opin. Lipidol. 2007, 18:258-262.
19. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
20. Yu R., Kim C.S., Kwon B.S., Kawada T. Mesenteric Adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 2006, 14:1353-1362.
21. Plastina P., Meijerink J., Vincken J.-P., Gruppen H., Witkamp R., Gabriele B. Selective synthesis of unsaturated N-acylethanolamines by lipase-catalyzed N-acylation of ethanolamine with unsaturated fatty acids. Lett. Org. Chem. 2009, 6:444-447.
22. Balvers M.G.J., Verhoeckx K.C.M., Witkamp R.F. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877:1583-1590.
23. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 2008, 51:1356-1367.
24. Eckardt K., Sell H., Taube A., Koenen M., Platzbecker B., Cramer A., Horrighs A., Lehtonen M., Tennagels N., Eckel J. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 2009, 52:664-674.
25. Rouzer C.A., Marnett L.J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 2008, 283:8065-8069.
26. Yan H., Kermouni A., Abdel-Hafez M., Lau D.C.W. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J. Lipid Res. 2003, 44:424-429.
27. Bradley R.L., Fisher F.M., Maratos-Flier E. Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes. Obesity 2008, 16:938-944.
28. Weldon S.M., Mullen A.C., Loscher C.E., Hurley L.A., Roche H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 2007, 18:250-258.
29. Plastina P., Meijerink J., Vincken J.-P., Poland M., Witkamp R.F. Inhibition of nitric oxide production in RAW264.7 macrophages by N-acyl ethanolamides. Naunyn. Schmiedebergs Arch. Pharmacol. 2009, 380. 268-268.
30. Roche R., Hoareau L., Bes-Houtmann S., Gonthier M.P., Laborde C., Baron J.F., Haffaf Y., Cesari M., Festy F. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem. Cell Biol. 2006, 126:177-187.
31. Sheskin T., Hanus L., Slager J., Vogel Z., Mechoulam R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 1997, 40:659-667.
32. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl Acad. Sci. USA 1993, 90:7656-7660.
33. Wood J.T., Williams J.S., Pandarinathan L., Courville A., Keplinger M.R., Janero D.R., Vouros P., Makriyannis A., Lammi-Keefe C.J. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters. Clin. Chem. Lab. Med. 2008, 46:1289-1295.